# FDA Inspection 1260228 - Lazurite Inc. - February 07, 2025

Source: https://www.keypedia.com/records/fda_inspections/lazurite-inc/10325c86-0828-46d2-8525-e9979dd23c61
Source feed: FDA_Inspections

> FDA Inspection 1260228 for Lazurite Inc. on February 07, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260228
- Company Name: Lazurite Inc.
- Inspection Date: 2025-02-07
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1260228 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/lazurite-inc/373a5bbf-d1cb-40f3-af16-f8d4e8c790eb)
- [FDA Inspection 1260228 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/lazurite-inc/194b991f-71a5-4a6f-a35d-db2b80ce12cc)
- [FDA Inspection 1260228 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/lazurite-inc/92206351-bd8b-4440-8377-e395d2447b03)

Company: https://www.keypedia.com/companies/lazurite-inc/e8bc21ea-a163-4af7-bd27-00a071256f5e

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7